| # | Drug | Count |
|---|---|---|
| 0 | FLUTICASONE PROPIONATE | 10 |
| 1 | FLUTICASONE PROPIONATE NASAL | 7 |
| 2 | DEXAMETHASONE | 6 |
| 3 | DEXAMETHASONE 1.5 MG | 6 |
| 4 | OMEPRAZOLE | 5 |
| 5 | OMEPRAZOLE MAGNESIUM | 5 |
| 6 | RALTEGRAVIR | 4 |
| 7 | TRIAMCINOLONE ACETONIDE | 4 |
| 8 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 4 |
| 9 | BUDESONIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE | 2 | 0.0025 |
| 1 | RALTEGRAVIR | 4 | 0.0008 |
| 2 | DARUNAVIR ETHANOLATE AND COBICISTAT | 1 | 0.0006 |
| 3 | DOBUTAMINE | 1 | 0.0003 |
| 4 | FLUTICASONE PROPIONATE NASAL | 7 | 0.0002 |
| 5 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 2 | 0.0002 |
| 6 | BECLOMETHASONE DIPROPIONATE | 1 | 0.0002 |
| 7 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 4 | 0.0002 |
| 8 | TRIAMCINOLONE ACETONIDE | 4 | 0.0001 |
| 9 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 4 | 0.0001 |
| 2 | Anticholinergic [EPC] | 1 | 0.0001 |
| 3 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 4 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 5 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 2 | 0.0000 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Microtubule Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Corticosteroid [EPC] | 15 | 0.0000 |